Acic Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ACIC PHARMS, and what generic and branded alternatives to ACIC PHARMS drugs are available?
ACIC PHARMS has six approved drugs.
Drugs and US Patents for Acic Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acic Pharms | DOCETAXEL | docetaxel | INJECTABLE;INJECTION | 216677-002 | Feb 28, 2024 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Acic Pharms | PANTOPRAZOLE SODIUM | pantoprazole sodium | INJECTABLE;INTRAVENOUS | 209524-001 | Aug 30, 2021 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Acic Pharms | CELECOXIB | celecoxib | CAPSULE;ORAL | 212925-002 | Dec 9, 2020 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.